0001104659-20-022826.txt : 20200219
0001104659-20-022826.hdr.sgml : 20200219
20200219162304
ACCESSION NUMBER: 0001104659-20-022826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Hunter C
CENTRAL INDEX KEY: 0001636385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 20630079
MAIL ADDRESS:
STREET 1: C/O GENESEE & WYOMING INC.
STREET 2: 20 WEST AVENUE
CITY: DARIEN
STATE: CT
ZIP: 06820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
a4.xml
4
X0306
4
2020-02-14
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001636385
Smith Hunter C
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
17.87
2020-02-14
4
A
0
82000
0
A
2030-02-13
Common Stock
82000
82000
D
This option was granted on February 14, 2020 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 14, 2020.
/s/ Hunter C. Smith
2020-02-19